Concepedia

H.E. Shannon

HS

6

Publications

332

Citations

6

H-Index

1984

Active since

Affiliations

National Institute on Drug Abuse(Current)

H.E. Shannon is an author at National Institute on Drug Abuse specializing in medicine, medicinal chemistry, and pharmacotherapy.

Top concepts

Publications per year

1984–2001

6

Publications

6

Detrusor Regeneration in the Rat Using Porcine Small Intestinal Submucosal Grafts: Functional Innervation and Receptor Expression

Jacob Vaught, Bradley P. Kropp, Barry D. Sawyer et al. · The Journal of Urology · 1996 · 169 citations

m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors

Scott D. Gleason, Virginia L. Lucaites, H.E. Shannon et al. · Behavioural Pharmacology · 2001 · 53 citations

, , +19

β-carboline-3-carboxylate-t-butyl ester: A selective BZ1 benzoiazepine receptor antagonist

H.E. Shannon, Fil Guzman, James M. Cook · Life Sciences · 1984 · 48 citations

, , +5

Pharmacological mechanisms of action of flupirtine: a novel, centrally acting, nonopioid analgesic evaluated by its discriminative effects in the rat.

Michael D.B. Swedberg, H.E. Shannon, B Nickel et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 24 citations

D-16949 (anpirtoline): a novel serotonergic (5-HT1B) psychotherapeutic agent assessed by its discriminative effects in the rat.

Michael D.B. Swedberg, H.E. Shannon, B Nickel et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 23 citations

Rows per page

1–5 of 6